Facilitators and barriers for implementation of a decentralized hepatitis C care chain for people who use drugs in Dutch addiction care
Implementation of HCV care within addiction care was generally enthusiastically received by participants. Identified organizational, staff, patient, and HCV treatment-related barriers and facilitators can aid in the implementation of integrated HCV-addiction care, thus contributing to WHO HCV elimination goals.
Authors
- Hannah Ellerbroek (ORCID: https://orcid.org/0000-0001-9471-6779)
- Arnt Schellekens (ORCID: https://orcid.org/0000-0002-7715-5209)
- Floor A. C. Berden (ORCID: https://orcid.org/0000-0003-1899-4421)
- Daan W. Von den Hoff (ORCID: https://orcid.org/0000-0002-4567-2391)
- Joost P.H. Drenth (ORCID: https://orcid.org/0000-0001-8027-3073)
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Nijmegen Institute for Scientist Practitioners in Addiction (NL)
- Jeroen Bosch Ziekenhuis (NL)
Publication Details
- Journal
- Drug and Alcohol Dependence
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1016/j.drugalcdep.2025.112759
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Gilead Sciences
- AbbVie